knowledge

ACE-031 Dosing Protocols

Quick Answer

Typical ACE-031 dosing: 0.5-3 mg/kg IV every 2 weeks (clinical research doses only) Every 2 weeks. Multiple protocols available for different goals.

Key Facts

  • Product: ACE-031
  • Category: gh
  • Section: Dosing Protocols
  • Main Article: [What Is ACE-031?](/knowledge/what-is-ace-031)
  • Protocols: 2
  • Typical Dose: 0.5-3 mg/kg IV every 2 weeks (clinical research doses only)
  • Frequency: Every 2 weeks

Related Products

ACE-031 Dosing Protocols

Proper dosing of ACE-031 depends on the research objective. Evidence-based protocols from published studies are detailed below.

Dosing Protocols

Quick Reference

  • Typical Dose: 0.5-3 mg/kg IV every 2 weeks (clinical research doses only)
  • Frequency: Every 2 weeks
  • Cycle Length: Clinical trials used 4-12 week treatment periods
  • Storage: 2-8°C; protect from light. Not commercially available.

Detailed Protocols by Goal

Goal Dose Frequency Route
Phase 1 Research Protocol (Healthy Volunteers) 0.1-3 mg/kg Single IV dose IV infusion
Phase 2 Research Protocol (DMD) 0.5-2.5 mg/kg Every 2 weeks IV or SubQ

Related Sections

Deep Dives: Key Benefits | Mechanism of Action | Research Indications | Side Effects & Safety | Interactions & Stacking | What to Expect Timeline | FAQ | References & Studies | Quality Checklist

Product: ACE-031 — ≥98% (HPLC verified) · COA available · 1mg

Disclaimer: This compound is supplied for qualified research and laboratory purposes only. Not for human consumption, therapeutic use, or any application outside controlled research environments.

RaysunPeptide — Southeast Asia-based peptide manufacturer supplying research-grade compounds with HPLC/MS verification and Certificates of Analysis. B2B and qualified research applications.